In-vitro models & assays to identify novel therapies for neuroinflammatory diseases supports researchers developing human-centered models and assays to discover and optimize small-molecule treatments.
Artificial intelligence in cell culture media and process development supports researchers building adaptable models to optimize media feeds across mammalian hosts, improving bioprocess efficiency and conserving resources.
Advancing Molecule Synthesis and Discovery supports organic-synthesis researchers using SYNTHIA® to plan novel molecules or analogue compound libraries and accelerate laboratory work.
Innovative Approaches to Economical Remediation of Contaminated High Volume Materials supports research teams developing scalable, sustainable ways to clean lightly contaminated soil and water, especially HCH pollution.
Pfizer Inc. funds education projects advancing knowledge of new mechanisms and emerging treatments, especially EZH2 inhibition, in metastatic castration resistant prostate cancer (mCRPC).